Novel treatment strategies in congenital adrenal hyperplasia.

about

Latest Insights on the Etiology and Management of Primary Adrenal Insufficiency in Children.Psychological adjustment, quality of life, and self-perceptions of reproductive health in males with congenital adrenal hyperplasia: a systematic review

P2860

Q49165205-00D5F47A-AB57-40F8-A7F5-5128054FA597 Q57137398-8FD88436-B5D9-4DE2-9DE6-8979F9AC7F3F

P2860

Novel treatment strategies in congenital adrenal hyperplasia.

Item

http://www.wikidata.org/entity/Q36981641

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Novel treatment strategies in congenital adrenal hyperplasia.

@en

type

Item

label

Novel treatment strategies in congenital adrenal hyperplasia.

@en

prefLabel

Novel treatment strategies in congenital adrenal hyperplasia.

@en

P1476

Novel treatment strategies in congenital adrenal hyperplasia.

@en

P2093

Adina F Turcu

http://www.w3.org/2001/XMLSchema#string

Richard J Auchus

http://www.w3.org/2001/XMLSchema#string

P2860

Abiraterone in metastatic prostate cancer without previous chemotherapy

Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline

Abiraterone and increased survival in metastatic prostate cancer

Amplitude, but not frequency, modulation of adrenocorticotropin secretory bursts gives rise to the nyctohemeral rhythm of the corticotropic axis in man.

A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.

A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia.

Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency.

Subcutaneous pulsatile glucocorticoid replacement therapy.

Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients.

P304

225-232

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MED.0000000000000256

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27032061

http://www.w3.org/2001/XMLSchema#string

P921

birth defect

P932

4898193

http://www.w3.org/2001/XMLSchema#string

Novel treatment strategies in congenital adrenal hyperplasia.

about

P2860

P2860

Novel treatment strategies in congenital adrenal hyperplasia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932